SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Agenus Inc. (AGEN) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Core Points - A shareholder class action lawsuit has been filed against Agenus Inc. alleging false and misleading statements regarding the effectiveness of its combination therapy of botensilimab and balstilimab [1] - The lawsuit claims that the clinical results and regulatory prospects of botensilimab and balstilimab were overstated, impacting investor perceptions [1] Legal Context - Investors who purchased shares of Agenus between January 23, 2023, and July 17, 2024, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline to request appointment as lead plaintiff in the case is November 5, 2024 [3]